Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.


  1. Home


  2. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.


  3. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

Psaty BM, Weiss NS, Furberg CD, Koepsell TD, Siscovick DS, Rosendaal FR, Smith NL, Heckbert SR, Kaplan RC, Lin D, Fleming TR, Wagner EH. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascu

Upcoming Events

Full Calendar


News Categories